{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:20Z","timestamp":1791329000062,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"49","license":[{"start":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T00:00:00Z","timestamp":1178496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T00:00:00Z","timestamp":1178496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2007,10,25]]},"DOI":"10.1038\/sj.onc.1210503","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T14:46:53Z","timestamp":1178549213000},"page":"6968-6978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling"],"prefix":"10.1038","volume":"26","author":[{"given":"K","family":"Shtiegman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B S","family":"Kochupurakkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Citri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ben-Basat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,7]]},"reference":[{"key":"BF1210503_CR1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/0008-5472.226.65.1","volume":"65","author":"J Amann","year":"2005","unstructured":"Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H et al. (2005). Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 65: 226\u2013235.","journal-title":"Cancer Res"},{"key":"BF1210503_CR2","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1074\/jbc.271.9.5251","volume":"271","author":"J Baulida","year":"1996","unstructured":"Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G . (1996). All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 271: 5251\u20135257.","journal-title":"J Biol Chem"},{"key":"BF1210503_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0955-0674(03)00004-8","volume":"15","author":"I Dikic","year":"2003","unstructured":"Dikic I, Giordano S . (2003). Negative receptor signalling. Curr Opin Cell Biol 15: 128\u2013135.","journal-title":"Curr Opin Cell Biol"},{"key":"BF1210503_CR4","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1073\/pnas.0409773102","volume":"102","author":"JA Engelman","year":"2005","unstructured":"Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C et al. (2005). ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA 102: 3788\u20133793.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210503_CR5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.0409610102","volume":"102","author":"LM Friedman","year":"2005","unstructured":"Friedman LM, Rinon A, Schechter B, Lyass L, Lavi S, Bacus SS et al. (2005). Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy. Proc Natl Acad Sci USA 102: 1915\u20131920.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210503_CR6","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","volume":"16","author":"D Graus Porta","year":"1997","unstructured":"Graus Porta D, Beerli RR, Daly JM, Hynes NE . (1997). ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647\u20131655.","journal-title":"EMBO J"},{"key":"BF1210503_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1677\/erc.0.0080151","volume":"8","author":"NE Hynes","year":"2001","unstructured":"Hynes NE, Horsch K, Olayioye MA, Badache A . (2001). The ErbB receptor tyrosine family as signal integrators. Endocr Relat Cancer 8: 151\u2013159.","journal-title":"Endocr Relat Cancer"},{"key":"BF1210503_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/j.1460-2075.1996.tb00356.x","volume":"15","author":"D Karunagaran","year":"1996","unstructured":"Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus Porta D, Ratzkin BJ et al. (1996). ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15: 254\u2013264.","journal-title":"EMBO J"},{"key":"BF1210503_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMoa044238","volume":"352","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M et al. (2005). EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. New Engl J Med 352: 786\u2013792.","journal-title":"New Engl J Med"},{"key":"BF1210503_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0092-8674(89)90843-X","volume":"58","author":"Y Kokai","year":"1989","unstructured":"Kokai Y, Myers JN, Wada T, Brown VI, LeVea CM, Davis JG et al. (1989). Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58: 287\u2013292.","journal-title":"Cell"},{"key":"BF1210503_CR11","first-page":"1117","volume":"12","author":"G Levkowitz","year":"1996","unstructured":"Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M, Yarden Y . (1996). Coupling of the c-Cbl protooncogene product to ErbB-1\/EGF-receptor but not to other ErbB proteins. Oncogene 12: 1117\u20131125.","journal-title":"Oncogene"},{"key":"BF1210503_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1097-2765(00)80231-2","volume":"4","author":"G Levkowitz","year":"1999","unstructured":"Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I et al. (1999). Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl\/Sli-1. Mol Cell 4: 1029\u20131040.","journal-title":"Mol Cell"},{"key":"BF1210503_CR13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW et al. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129\u20132139.","journal-title":"N Engl J Med"},{"key":"BF1210503_CR14","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/sj.onc.1207390","volume":"23","author":"MD Marmor","year":"2004","unstructured":"Marmor MD, Yarden Y . (2004). Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23: 2057\u20132070.","journal-title":"Oncogene"},{"key":"BF1210503_CR15","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1128\/MCB.19.10.6845","volume":"19","author":"SK Muthuswamy","year":"1999","unstructured":"Muthuswamy SK, Gilman M, Brugge JS . (1999). Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol Cell Biol 19: 6845\u20136857.","journal-title":"Mol Cell Biol"},{"key":"BF1210503_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1007249004222","volume":"218","author":"X Ouyang","year":"2001","unstructured":"Ouyang X, Gulliford T, Zhang H, Smith G, Huang G, Epstein RJ . (2001). Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer. Mol Cell Biochem 218: 47\u201354.","journal-title":"Mol Cell Biochem"},{"key":"BF1210503_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S et al. (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497\u20131500.","journal-title":"Science"},{"key":"BF1210503_CR18","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I et al. (2004). EGF receptor gene mutations are common in lung cancers from \u2018never smokers\u2019 and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306\u201313311.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"BF1210503_CR19","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","volume":"2","author":"William Pao","year":"2005","unstructured":"Pao W, Miller VA, Politi KA, Rieli GJ, Somwar R, Zakowski MF et al. (2005). Acquired resistance of lung adenocarcinomas to Gefitinib or Erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Medicine 2: e73.","journal-title":"PLoS Medicine"},{"key":"BF1210503_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/416451a","volume":"416","author":"S Polo","year":"2002","unstructured":"Polo S, Sigismund S, Faretta M, Guidi M, Capua MR, Bossi G et al. (2002). A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 416: 451\u2013455.","journal-title":"Nature"},{"key":"BF1210503_CR21","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1073\/pnas.0409817102","volume":"102","author":"S Sigismund","year":"2005","unstructured":"Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P et al. (2005). Clathrin-independent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci USA 102: 2760\u20132765.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210503_CR22","doi-asserted-by":"crossref","first-page":"14661","DOI":"10.1016\/S0021-9258(17)36676-0","volume":"269","author":"MX Sliwkowski","year":"1994","unstructured":"Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A et al. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661\u201314665.","journal-title":"J Biol Chem"},{"key":"BF1210503_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1126\/science.1101637","volume":"305","author":"R Sordella","year":"2004","unstructured":"Sordella R, Bell DW, Haber DA, Settleman J . (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163\u20131167.","journal-title":"Science"},{"key":"BF1210503_CR24","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.1158\/0008-5472.CAN-04-1905","volume":"64","author":"S Tracy","year":"2004","unstructured":"Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Janne PA . (2004). Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res 64: 7241\u20137244.","journal-title":"Cancer Res"},{"key":"BF1210503_CR25","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1093\/emboj\/18.12.3348","volume":"18","author":"H Waterman","year":"1999","unstructured":"Waterman H, Alroy I, Strano S, Seger R, Yarden Y . (1999). The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing. EMBO J 18: 3348\u20133358.","journal-title":"EMBO J"},{"key":"BF1210503_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/emboj\/21.3.303","volume":"21","author":"H Waterman","year":"2002","unstructured":"Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A et al. (2002). A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J 21: 303\u2013313.","journal-title":"EMBO J"},{"key":"BF1210503_CR27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1126\/science.2305263","volume":"247","author":"A Wells","year":"1990","unstructured":"Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenfeld MG . (1990). Ligand-induced transformation by a non-internalizing epidermal growth factor receptor. Science 247: 962\u2013964.","journal-title":"Science"},{"key":"BF1210503_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-0854.2001.020103.x","volume":"2","author":"HS Wiley","year":"2001","unstructured":"Wiley HS, Burke PM . (2001). Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic 2: 12\u201318.","journal-title":"Traffic"},{"key":"BF1210503_CR29","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.1074\/jbc.274.13.8865","volume":"274","author":"R Worthylake","year":"1999","unstructured":"Worthylake R, Opresko LK, Wiley HS . (1999). ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. J Biol Chem 274: 8865\u20138874.","journal-title":"J Biol Chem"},{"key":"BF1210503_CR30","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1158\/0008-5472.CAN-06-1042","volume":"66","author":"S Yang","year":"2006","unstructured":"Yang S, Qu S, Perez-Tores M, Sawai A, Rosen N, Solit DB et al. (2006). Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Cancer Res 66: 6990\u20136997.","journal-title":"Cancer Res"},{"key":"BF1210503_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX . (2001). Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127\u2013137.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210503","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:50:47Z","timestamp":1683831047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,7]]},"references-count":31,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2007,10,25]]}},"alternative-id":["BF1210503"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210503","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,7]]},"assertion":[{"value":"12 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}